NMR Studies on Interactions between Diperoxovanadate and N-Substituted Picolinamide

为了探讨有机配体上取代基团对反应平衡的影响,在模拟生理条件下(0.15mol/LNaCl溶液),应用多核(1H,13C和51V)多维(COSY和DOSY)NMR以及变温技术等谱学方法研究双过氧钒配合物[OV(O2)2(D2O)]-/[OV(O2)2(HOD)]-与N-取代皮考啉酰胺的相互作用.它们反应性从强到弱的顺序为:N-甲基-皮考啉酰胺≈N-(2-羟乙基)-皮考啉酰胺>N-乙基-皮考啉酰胺>N-丙基-皮考啉酰胺,这说明了皮考啉酰胺N上取代基的电子效应影响反应.竞争配位导致一系列新的7配位的过氧钒物种生成,而利用上述谱学方法则有助于揭示此类相互作用体系的反应过程和配位机制.To understand the substituting effects of organic ligands on the reaction equilibrium, the interac- tions between diperoxovanadate complex [OV(O2)2(D2O)]-/[OV(O2)2(HOD)]- and a series of N-substituted picolinamide ligands in solution were explored using multinuclear (1H, 13C, and 51V) magnetic resonance, COSY, DOSY, and variable temperature NMR in 0.15 mol/L NaCl ionic medium for mimicking the physio- logical conditions. The order of reactive capability of the picolinamide-like ligands with [OV(O2)2(D2O)]-/ [OV(O2)2(HOD)]? is as follows: N-methylpicolinamide ≈ N-(2-hydroxyethyl)picolinamide > N-ethyl- picolinamide>N-propylpicolinamide. The substituting group influences the reactivity by an electron effect. Competitive coordination interactions result in a series of new seven-coordinated peroxovanadate species [OV(O2)2L]-(L=N-substituted picolinamide).973子课题(No.2003CB716005);; 国家自然科学基金(No.20772027);; 湖南省自然科学基金(No.06JJ30004);; 中国博士后科学基金(No.20070410805);; 卫生部(福建省)卫生教育联合攻关计划(No.3502Z20051027);; 厦门市重大疾病攻关研究基金(No.Wkj2005-2-019);; 固体表面物理化学国家重点实验室开放基金;; 湖南科技大学博士基金(No.E-55107)资助项目

NMR studies on interactions between diperoxovanadate and N-substituted picolinamide

To understand the substituting effects of organic ligands on the reaction equilibrium, the interactions between diperoxovanadate complex [OV(O-2)(2)(D2O)(-)/[OV(O-2)(2)(HOD)](-) and a series of N-substituted picolinamide ligands in solution were explored using multinuclear (H-1, C-13, and V-51) magnetic resonance, COSY, DOSY, and variable temperature NMR in 0.15 mol/L NaCl ionic medium for mimicking the physiological conditions. The order of reactive capability of the picolinamide-like ligands with [OV(O-2)(2)(D2O)](-)/[OV(O-2)(2)(HOD)](-) is as follows: N-methylpicolinamide approximate to N-(2-hydroxyethyl)picolinamide > N-ethylpicolinamide>N-propylpicolinamide. The substituting group influences the reactivity by an electron effect. Competitive coordination interactions result in a series of new seven-coordinated peroxovanadate species [OV(O-2)(2)L](-) (L=N-substituted picolinamide)

Knowledge Mining Based on Rough Set Theory and Multi Agent System

提出一种基于微粒群优化的粗集知识约简算法并获取规则，该算法解决了启发式算法无法全局搜索进行约简的问题。通过利用离散微粒群算法，优化了知识表达系统中条件属性对决策属性的依赖度，在矿井调度信息的应用中验证了其有效性。<br /

撞击流反应器内气固两相流动的数值模拟

采用标准k-&epsilon;湍流模型和颗粒轨道模型模拟了水平撞击流反应器内的气相流场和颗粒运动,实验采用压力计和PV4A光纤速度测量仪测量了整体压力损失和颗粒沿喷嘴轴线的速度变化,模拟得到的规律和实验结果基本吻合。通过模拟还得到了单侧颗粒进料时的颗粒运动特征、颗粒的最大渗透深度和平均飞行时间等信息。结果表明,撞击区域集中在2～3倍喷嘴直径范围之内,气流场的速度和压力呈对称分布,颗粒进入反向气流后速度急剧衰减,最大渗透深度约为喷嘴直径的2倍,颗粒的平均飞行时间在0.7 s～1.8 s之间。随着喷嘴气流速度的增加,颗粒物料更容易被气流带走

2005～2014年CERN野外台站气象观测场土壤含水量数据集

土壤水分是影响陆地–大气边界层能量和物质传输的重要因子。土壤水分含量是中国生态系统研究网络(CERN)陆地生态系统水环境长期定位观测的重要指标。截至2014年,CERN全国范围内包括农田、森林、草地、荒漠与湿地等生态类型的34个陆地生态系统台站,依据陆地水环境观测规范、质量保证与质量控制规范,设立观测样地,并开展土壤含水量的长期定位观测与数据汇交及质控工作。CERN水分分中心选取了这34个台站2005～2014年气象观测场的土壤含水量长期监测数据,通过进一步统一规范数据格式,形成了全国范围内较长时间序列的公开共享数据集,为土壤含水量时空动态的遥感反演、模型估算验证提供地面实测数据支撑

Aripiprazole versus other atypical antipsychotics for schizophrenia

BACKGROUND: In most western industrialised countries, second generation (atypical) antipsychotics are recommended as first line drug treatments for people with schizophrenia. In this review we specifically examine how the efficacy and tolerability of one such agent - aripiprazole - differs from that of other comparable second generation antipsychotics. OBJECTIVES: To evaluate the effects of aripiprazole compared with other atypical antipsychotics for people with schizophrenia and schizophrenia-like psychoses. SEARCH METHODS: We searched the Cochrane Schizophrenia Group Trials Register (November 2011), inspected references of all identified studies for further trials, and contacted relevant pharmaceutical companies, drug approval agencies and authors of trials for additional information. SELECTION CRITERIA: We included all randomised clinical trials (RCTs) comparing aripiprazole (oral) with oral and parenteral forms of amisulpride, clozapine, olanzapine, quetiapine, risperidone, sertindole, ziprasidone or zotepine for people with schizophrenia or schizophrenia-like psychoses. DATA COLLECTION AND ANALYSIS: We extracted data independently. For dichotomous data we calculated risk ratios (RR) and their 95% confidence intervals (CI) on an intention-to-treat basis based on a random-effects model. Where possible, we calculated illustrative comparative risks for primary outcomes. For continuous data, we calculated mean differences (MD), again based on a random-effects model. We assessed risk of bias for each included study. MAIN RESULTS: We included 12 trials involving 6389 patients. Aripiprazole was compared to olanzapine, risperidone and ziprasidone. All trials were sponsored by an interested drug manufacturer. The overall number of participants leaving studies early was 30% to 40%, limiting validity (no differences between groups).When compared with olanzapine no differences were apparent for global state (no clinically important change: n = 703, 1 RCT, RR short-term 1.00 95% CI 0.81 to 1.22; n = 317, 1 RCT, RR medium-term 1.08 95% CI 0.95 to 1.22) but mental state tended to favour olanzapine (n = 1360, 3 RCTs, MD total Positive and Negative Syndrome Scale (PANSS) 4.68 95% CI 2.21 to 7.16). There was no significant difference in extrapyramidal symptoms (n = 529, 2 RCTs, RR 0.99 95% CI 0.62 to 1.59) but fewer in the aripiprazole group had increased cholesterol levels (n = 223, 1 RCT, RR 0.32 95% CI 0.19 to 0.54) or weight gain of 7% or more of total body weight (n = 1095, 3 RCTs, RR 0.39 95% CI 0.28 to 0.54).When compared with risperidone, aripiprazole showed no advantage in terms of global state (n = 384, 2 RCTs, RR no important improvement 1.14 95% CI 0.81 to 1.60) or mental state (n = 372, 2 RCTs, MD total PANSS 1.50 95% CI -2.96 to 5.96).One study compared aripiprazole with ziprasidone (n = 247) and both the groups reported similar change in the global state (n = 247, 1 RCT, MD average change in Clinical Global Impression-Severity (CGI-S) score -0.03 95% CI -0.28 to 0.22) and mental state (n = 247, 1 RCT, MD change PANSS -3.00 95% CI -7.29 to 1.29).When compared with any one of several new generation antipsychotic drugs the aripiprazole group showed improvement in global state in energy (n = 523, 1 RCT, RR 0.69 95% CI 0.56 to 0.84), mood (n = 523, 1 RCT, RR 0.77 95% CI 0.65 to 0.92), negative symptoms (n = 523, 1 RCT, RR 0.82 95% CI 0.68 to 0.99), somnolence (n = 523, 1 RCT, RR 0.80 95% CI 0.69 to 0.93) and weight gain (n = 523, 1 RCT, RR 0.84 95% CI 0.76 to 0.94). Significantly more people given aripiprazole reported symptoms of nausea (n = 2881, 3 RCTs, RR 3.13 95% CI 2.12 to 4.61) but weight gain (7% or more of total body weight) was less common in people allocated aripiprazole (n = 330, 1 RCT, RR 0.35 95% CI 0.19 to 0.64). Aripiprazole may have value in aggression but data are limited. This will be the focus of another review. AUTHORS' CONCLUSIONS: Information on all comparisons are of limited quality, are incomplete and problematic to apply clinically. Aripiprazole is an antipsychotic drug with a variant but not absent adverse effect profile. Long-term data are sparse and there is considerable scope for another update of this review as new data emerges from the many Chinese studies as well as from ongoing larger, independent pragmatic trials

JUNO Sensitivity on Proton Decay p→νˉK+p\to \bar\nu K^+ Searches

The Jiangmen Underground Neutrino Observatory (JUNO) is a large liquid scintillator detector designed to explore many topics in fundamental physics. In this paper, the potential on searching for proton decay in $p\to \bar\nu K^+$ mode with JUNO is investigated.The kaon and its decay particles feature a clear three-fold coincidence signature that results in a high efficiency for identification. Moreover, the excellent energy resolution of JUNO permits to suppress the sizable background caused by other delayed signals. Based on these advantages, the detection efficiency for the proton decay via $p\to \bar\nu K^+$ is 36.9% with a background level of 0.2 events after 10 years of data taking. The estimated sensitivity based on 200 kton-years exposure is $9.6 \times 10^{33}$ years, competitive with the current best limits on the proton lifetime in this channel

JUNO sensitivity on proton decay p → ν K + searches*

The Jiangmen Underground Neutrino Observatory (JUNO) is a large liquid scintillator detector designed to explore many topics in fundamental physics. In this study, the potential of searching for proton decay in the $p\to \bar{\nu} K^+$ mode with JUNO is investigated. The kaon and its decay particles feature a clear three-fold coincidence signature that results in a high efficiency for identification. Moreover, the excellent energy resolution of JUNO permits suppression of the sizable background caused by other delayed signals. Based on these advantages, the detection efficiency for the proton decay via $p\to \bar{\nu} K^+$ is 36.9% ± 4.9% with a background level of $0.2\pm 0.05({\rm syst})\pm$$0.2({\rm stat})$ events after 10 years of data collection. The estimated sensitivity based on 200 kton-years of exposure is $9.6 \times 10^{33}$ years, which is competitive with the current best limits on the proton lifetime in this channel and complements the use of different detection technologies